However, the inhibitory effects of EE on post-stroke anxiety (PSA)-like behavior were attenuated by the treatment with HMGB1 inhibitor glycyrrhizin (Figure 2a; P<0.05). This evidence concerns the gene HMGB1 and Stroke.